Low Rates of PSA Screening Linked to Increase in Metastatic Prostate Cancer Will USPSTF's 2018 guidelines reverse this trend? Oct 25, 2022
High-Dose-Rate Brachytherapy Boost in Prostate Cancer Improves QOL Patients report better urinary and bowel function outcomes Oct 24, 2022
Clinical Decision Tool Cuts Inappropriate BMA Therapy in Prostate Cancer Study at VA center shows better disease-related bone healthcare Sep 18, 2022
Long-Term ADT With Radiation Helps Prevent Post-Prostatectomy Metastases However, no benefit seen with short-term hormone therapy versus radiotherapy alone Sep 13, 2022
Rezvilutamide Bests Bicalutamide in Metastatic Prostate Cancer Combined with ADT, the androgen-receptor inhibitor significantly improved OS, radiographic PFS Sep 07, 2022
A Light at the End of the Tunnel for Low-Risk Prostate Cancer? The MUSIC model might improve quality of life and prevent overtreatment Sep 02, 2022
How Realistic Is Radical Prostatectomy Without Prior Biopsy? German case series suggests it may be feasible Jul 12, 2022
MRI-Guided HIFU Effective in Intermediate-Risk Prostate Cancer QOL outcomes compared favorably with radical prostatectomy and radiotherapy, researchers said Jun 17, 2022
Xtandi During AS Reduced Progression Risk in Early Prostate Cancer Risk of disease progression cut by 46% versus those on active surveillance alone Jun 16, 2022
P53 Antagonist Shows Early Activity in Advanced Liposarcoma ASCO roundup: ADC targeting CD46 slows mCRPC, molecule stabilizes effects of "hot spot" mutation Jun 08, 2022
She Found Out She Had Prostate Cancer Then Eve Gammill, a transgender woman, fully embraced her feminine identity Jun 07, 2022
Just How Effective Is PSA Screening? Study finds test has better benefit/harm trade-off than originally thought May 18, 2022
Mental Health Issues Common, Often Overlooked in Prostate Cancer More than a third of patients with anxiety, depression, fear of recurrence/disease progression May 17, 2022
Urologists Are Helping Combat the Opioid Epidemic, Studies Suggest Three reports show success in reducing opioid prescribing May 16, 2022
End of the Line for a Failed Prostate Cancer Drug Orteronel misses mark in metastatic hormone-sensitive prostate cancer, after failures in mCRPC Apr 29, 2022
Another Link Between Prostate Cancer Hormone Tx and Impaired Cognition Strongest association with enzalutamide, but survival benefit outweighs effect, specialists say Apr 25, 2022
Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx Consistently low PSA levels failed to signal metastasis Apr 18, 2022
Genetic Score Shows Promise for Honing PSA Precision Fewer unnecessary biopsies projected with use of genetics-adjusted values Apr 12, 2022
$150K Prostate Cancer Drug Draws New Attention to 'March-In' Rights Advocates want Biden administration to enable Xtandi generics; industry warns against it Apr 06, 2022
Cancer May Heighten Odds of Guillain-Barre Syndrome Link strongest with hematologic malignancies as well as prostate, breast, and respiratory cancers Mar 03, 2022
Enzalutamide Rechallenge Yields Small PFS Boost in Metastatic Prostate Cancer Docetaxel-enzalutamide regimen may offer another option for men who progressed on AR inhibitor Feb 18, 2022
Two PARP Inhibitors Impress as First-Line Add-Ons in mCRPC In one case, rPFS benefit was seen regardless of HRR mutational status Feb 18, 2022
Darolutamide Improves OS in Metastatic Prostate Cancer The AR inhibitor plus standard therapy led to a 32% reduced risk of death versus placebo Feb 17, 2022
Active Cellular Immunotherapy Disappoints in Metastatic Prostate Cancer In combination with chemotherapy, no OS benefit seen with DCVAC/PCa over placebo Feb 10, 2022
We've Never Really Understood the Prostate Wolinsky reviews Ericka Johnson's new book, A Cultural Biography of the Prostate Jan 19, 2022
In Early Prostate Cancer, Black Men Do Better With Radiotherapy Than White Men "Unexpected" finding holds even though Black men are more likely to have high-risk features Dec 29, 2021
NCCN Reverses on Guideline Change for Surveillance in Prostate Cancer Active surveillance again preferred choice for "most" men with low-risk disease Dec 01, 2021
Mixed Results With RT Plus Short-Term ADT in Intermediate-Risk Prostate Cancer No survival benefit, but risk of biochemical failure, metastasis, cancer death improved Oct 28, 2021
Meta-Analysis Reaffirms Role of ADT With Radiotherapy in Prostate Cancer Prolonged adjuvant ADT also improved survival Oct 27, 2021
Potential New Standard for Post-Prostatectomy Radiotherapy Side effects at 2 years similar with hypofractionated versus conventional RT Oct 25, 2021
Cognitive Therapy Boosts Penile Injection Compliance Post-Prostatectomy Men became more comfortable with treatment to ward off ED, study suggests Oct 25, 2021
Benefits of Post-Op Penile Traction Therapy Hold Up Over Time Improvements in length, function seen at 9 months after prostatectomy Oct 23, 2021
Androgen-Targeting Combos Show Promise in Prostate Cancer Trials extend survival in hormone-sensitive disease Sep 21, 2021
Best Way to Recover Urinary Continence After Prostatectomy? Nerve-sparing prostatectomy, not rehab or duloxetine, most important factor Sep 13, 2021
Which Prostate Biopsy Is Best: Transrectal or Transperineal? Advocates for one may face uphill battle, debate at AUA meeting suggests Sep 13, 2021
Plant-Based Diet Tied to Better Urological Health in Men "Eat more plants for your prostate and your erections Sep 12, 2021
Darolutamide Tied to Symptom Control in Non-Metastatic Prostate Cancer Analysis of ARAMIS trial results also shows QoL benefits with androgen receptor inhibitor Sep 12, 2021
PSMA PET Plus MRI Better Detects Clinically Significant Prostate Cancers Increase in negative predictive value and improved sensitivity versus MRI alone Sep 01, 2021
ADT Options for Prostate Cancer Come Out Even for Heart Safety But low enrollment brought PRONOUNCE trial to an early close Aug 31, 2021
Robot-Assisted Prostatectomy Tied to Fewer Complications Taiwan study also saw shorter hospital stays versus open or laparoscopic surgeries Aug 25, 2021
